Volpara Solutions has won FDA 510(k) clearance for software designed to help radiologists meet the BI-RADS Atlas fifth-edition requirement to provide an overall assessment of the volume of attenuating tissues in the breast.

Determination of breast density fluctuates considerably from one exam to the next in any given woman. Such variability can both perplex the patient and drive unintended consequences into her care pathway.

Subsequent breast cancers occur in patients with just their own premenstrual history of the disease at close to the same rate as in patients with both personal and family breast-cancer history, according to a study published online Jan. 7 in Academic Radiology. 

The debate over CT radiation dose communications—does discussing the matter with patients lead them to make informed decisions or scare them away from tests they may need?—is just one part of a broader discussion on dose getting a wide national airing in the mainstream press.

Five score and 20 years ago this week—or six score flat, if you prefer—the word went out from William Roentgen’s lab to the world. The publicity came courtesy of an Austrian newspaper. 

According to a recent study published in JAMA Internal Medicine, the use of chest CT in hospital emergency departments (ED) to evaluate respiratory symptoms significantly jumped from 2001 to 2010.

A study of more than 2,500 women has found ultrasound just as good as mammography at detecting breast cancer. On the downside, ultrasound generated more false positives than mammography.

There is sufficient existing literature on which to base clinical decision rules separating patients with apparently minor but clinically serious head trauma—and thus in need of CT neuroimaging and prompt clinical intervention—from similarly alert and responsive head-trauma patients who would be better off avoiding the radiation exposure and the costs.